| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 具有粘接剂的机动车真空泵 | CN201580019310.0 | 2015-02-20 | CN106170629B | 2017-11-28 | 弗雷迪·舍恩瓦尔德; 本亚明·皮尔多克; 于尔根·雅库博夫斯基; 丹尼尔·齐尔; 卡斯滕·什采斯尼 |
| 本发明涉及一种机动车真空泵，所述机动车真空泵具有泵壳体面，在所述泵壳体面上安置有吸声罩，所述吸声罩对消声体积限界。 | ||||||
| 2 | 包含含有石蜡的元件（30；40）。包括可变形密封装置和长保存性的流体致动器 | CN201180065902.8 | 2011-11-14 | CN103380299B | 2017-02-22 | 托马斯·奥托; 约尔格·内斯特勒; 托马斯·格斯纳 |
| 本发明提供了流体致动器，包含基本的装置1，10），其包括在其中形成的至少一个腔体（6）、腔体（6）内的可活化物质（20）以及可变形密封装置。可至少部分地，通过适当的活化，转化可活化物质，示例地为电解液，并由此导致腔体（6）中的压力变化。可变形密封装置（30；4）用于密封腔体6）。密封装置包含含有石蜡的元件（30；40），且当活化可活化物质（20）由于可活化物质的压力的改变时，可使其变形。相应的制造方法包含下列步骤：提供基本的装置（1，10）；在基础装置（1，10）中形成腔体（6），在至少一个侧面上使其开口；将可活化物质（20）引入腔体（6）；和利用可变形密封装置（30；4）密封腔体，其中所述密封装置 | ||||||
| 3 | 具有粘接剂的机动车真空泵 | CN201580019310.0 | 2015-02-20 | CN106170629A | 2016-11-30 | 弗雷迪·舍恩瓦尔德; 本亚明·皮尔多克; 于尔根·雅库博夫斯基; 丹尼尔·齐尔; 卡斯滕·什采斯尼 |
| 本发明涉及一种机动车真空泵，所述机动车真空泵具有泵壳体面，在所述泵壳体面上安置有吸声罩，所述吸声罩对消声体积限界。 | ||||||
| 4 | 成型材料 | CN201280026145.8 | 2012-05-21 | CN103562307A | 2014-02-05 | 西村正朗; 缇奈珂·婉缇娜; 马提恩斯·得缪科 |
| 本发明以提供具有改善的比强度和比弹性模量并且具有优异的成型特性的成型材料为课题。根据本发明，提供含有酚醛树脂、碳纤维、聚醚砜和/或聚醚酰亚胺的成型材料。 | ||||||
| 5 | 用于贮存药剂的容器和方法 | CN201310315459.6 | 2013-05-03 | CN103417371A | 2013-12-04 | J·阿拉尔孔; W·里格斯比; J·霍瓦特; D·科米里迪; R·J·佩蒂斯 |
| 本发明提供用于贮存药剂以延长贮存时间的容器和方法。通过减少药剂中稳定剂的损失来改进药剂的贮存时间。贮存容器由聚烯烃形成，该聚烯烃包含的稳定剂量能够减少或抑制药剂中稳定剂的转移。聚烯烃容器利用脂肪酸酰胺如芥酸酰胺形成，用于稳定含有用作胰岛素稳定剂的间甲酚和/或苯酚的胰岛素。结合在容器中的脂肪酸酰胺抑制和/或降低间甲酚和/或苯酚转移进入聚烯烃中的转移速率，以便延长胰岛素的贮存期。所述容器可以是注射器，如预装填注射器、贮存瓶、或注射泵的流动路径。 | ||||||
| 6 | 包括可变形密封装置和长保存性的流体致动器 | CN201180065902.8 | 2011-11-14 | CN103380299A | 2013-10-30 | 托马斯·奥托; 约尔格·内斯特勒; 托马斯·格斯纳 |
| 本发明提供了流体致动器，包含基本的装置（1，10），其包括在其中形成的至少一个腔体（6）、腔体（6）内的可活化物质（20）以及可变形密封装置。可至少部分地，通过适当的活化，转化可活化物质，示例地为电解液，并由此导致腔体（6）中的压力变化。可变形密封装置（30；4）用于密封腔体（6）。密封装置包含含有石蜡的元件（30；40），且当活化可活化物质（20）由于可活化物质的压力的改变时，可使其变形。相应的制造方法包含下列步骤：提供基本的装置（1，10）；在基础装置（1，10）中形成腔体（6），在至少一个侧面上使其开口；将可活化物质（20）引入腔体（6）；和利用可变形密封装置（30；4）密封腔体，其中所述密封装置包含含有石蜡的元件（30；40）。 | ||||||
| 7 | 使用了导电性高分子的流体运送装置 | CN200980115107.8 | 2009-08-25 | CN102016314A | 2011-04-13 | 生岛君弥; 横山和夫 |
| 一种使用了导电性高分子的流体运送装置，其具备：带吸入喷出流体的泵的功能且内部充满流体的泵室(107、108)、构成泵室壁面的一部分的框体部(102)、由进行电解伸缩的导电性高分子膜形成并构成泵室壁面的一部分的隔膜(103、104)、内部所含的电解液的一部分与隔膜相接的电解液室(109)、向隔膜施加电压的电源、和通过使电解液室的壁面的一部分移动或变形而使所述隔膜的压力维持在规定范围内的压力维持部(1100、1110、1111、1112、1114、1115)。 | ||||||
| 8 | Fluidic actuator comprising deformable seal arrangement and long storability | US13901109 | 2013-05-23 | US09291285B2 | 2016-03-22 | Thomas Otto; Joerg Nestler; Thomas Gessner |
| A fluidic actuator includes a basic arrangement having at least one cavity formed therein, an activatable substance within the cavity, and a deformable seal arrangement. The activatable substance, exemplarily an electrolyte, may be converted, at least partly, by suitable activation and thus cause a change in pressure in the cavity. The deformable seal arrangement serves for sealing the cavity. The seal arrangement includes an element containing paraffin and may be deformed when activating the activatable substance due to the change in pressure of the activatable substance. A corresponding method of manufacturing includes the following steps: providing the basic arrangement; forming a cavity, which is open on at least one side, in the basic arrangement; introducing the activatable substance into the cavity; and sealing the cavity using the deformable seal arrangement which includes an element containing paraffin. | ||||||
| 9 | Container and method for storing a pharmaceutical agent | US13463509 | 2012-05-03 | US09068565B2 | 2015-06-30 | Javier Alarcon; William Riggsbee; Joshua Horvath; Dinesh Kommireddy; Ron J. Pettis |
| A container and method for storing a pharmaceutical agent are provided for enhancing the storage time. The storage time of the pharmaceutical agent is improved by reducing the loss of stabilizing agents in the pharmaceutical agent. The storage container is formed from a polyolefin that includes a stabilizing agent in an amount effective to reduce or inhibit the migration of stabilizing agents in the pharmaceutical agent. The polyolefin container is formed with a fatty acid amide such as erucamide for stabilizing insulin that contains m-cresol and/or phenol as stabilizing agents for the insulin. The fatty acid amide incorporated in the container inhibits and/or reduces the rate of migration of the m-cresol and/or phenol into the polyolefin to extend the storage life of the insulin. The container can be a syringe, such as a pre-filled syringe, a storage vial or the flow path of an infusion pump. | ||||||
| 10 | Motor vehicle vacuum pump having an adhesive | US15303113 | 2015-02-20 | US10094383B2 | 2018-10-09 | Freddy Schonwald; Benjamin Pyrdok; Jurgen Jakubowski; Daniel Ziehr; Carsten Sczesny |
| The invention relates to a motor vehicle vacuum pump having a pump housing surface, on which a noise absorption cap is mounted, said cap defining a noise damping volume. | ||||||
| 11 | Fluid metering device | US12745880 | 2008-12-03 | US09995295B2 | 2018-06-12 | Mark Banister; Dale L. Fanter |
| A device for metering fluids comprising a fluid chamber with one inlet or outlet port, at least one sidewall and a movable separator that is in contact with and separates the fluid in the chamber from the other components of the device, a porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separator, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, a fluid gate located at some point between actuator hydrating solution reservoir and the polymer actuator, effectively keeping actuator dry, and an external shell to hold all components so that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chamber. | ||||||
| 12 | CONTAINER AND METHOD FOR STORING A PHARMACEUTICAL AGENT | US13463509 | 2012-05-03 | US20130296235A1 | 2013-11-07 | Javier ALARCON; William RIGGSBEE; Joshua HORVATH; Dinesh KOMMIREDDY; Ron J. PETTIS |
| A container and method for storing a pharmaceutical agent are provided for enhancing the storage time. The storage time of the pharmaceutical agent is improved by reducing the loss of stabilizing agents in the pharmaceutical agent. The storage container is formed from a polyolefin that includes a stabilizing agent in an amount effective to reduce or inhibit the migration of stabilizing agents in the pharmaceutical agent. The polyolefin container is formed with a fatty acid amide such as erucamide for stabilizing insulin that contains m-cresol and/or phenol as stabilizing agents for the insulin. The fatty acid amide incorporated in the container inhibits and/or reduces the rate of migration of the m-cresol and/or phenol into the polyolefin to extend the storage life of the insulin. The container can be a syringe, such as a pre-filled syringe, a storage vial or the flow path of an infusion pump. | ||||||
| 13 | FLUIDIC ACTOR COMPRISING DEFORMABLE SEAL ARRANGEMENT AND LONG STORABILITY | US13901109 | 2013-05-23 | US20130255812A1 | 2013-10-03 | Thomas OTTO; Joerg NESTLER; Thomas GESSNER |
| A fluidic actuator includes a basic arrangement having at least one cavity formed therein, an activatable substance within the cavity, and a deformable seal arrangement. The activatable substance, exemplarily an electrolyte, may be converted, at least partly, by suitable activation and thus cause a change in pressure in the cavity. The deformable seal arrangement serves for sealing the cavity. The seal arrangement includes an element containing paraffin and may be deformed when activating the activatable substance due to the change in pressure of the activatable substance. A corresponding method of manufacturing includes the following steps: providing the basic arrangement; forming a cavity, which is open on at least one side, in the basic arrangement; introducing the activatable substance into the cavity; and sealing the cavity using the deformable seal arrangement which includes an element containing paraffin. | ||||||
| 14 | MOLDING MATERIAL | EP12792347.2 | 2012-05-21 | EP2716708A1 | 2014-04-09 | NISHIMURA, Masaaki; VAN THIENEN, Tinneke; DE MUYNCK, Mathias |
The present invention has an objective to provide a molding material which has the improved specific strength and specific elastic modulus and which has excellent molding properties. According to the present invention, a molding material including a phenolic resin, carbon fibers, and a polyethersulfone and/or a polyetherimide is provided. |
||||||
| 15 | 医薬品を保管するための容器および方法 | JP2015510384 | 2013-04-30 | JP6141413B2 | 2017-06-07 | ハビエル アラルコン; ウィリアム リグスビー; ジョシュア ホルバート; ディニッシュ コミレディ; ロナルド ペティス |
| 16 | スクロール成形品 | JP2011121343 | 2011-05-31 | JP5715884B2 | 2015-05-13 | 西村 正朗; テネケ バン ティネン; マティアス ディ マーンク; 高倉 朗; 小島 和重 |
| 17 | 医薬品を保管するための容器および方法 | JP2015510384 | 2013-04-30 | JP2015517328A | 2015-06-22 | アラルコン ハビエル; リグスビー ウィリアム; ホルバート ジョシュア; コミレディ ディニッシュ; ペティス ロナルド |
| 貯蔵時間を延長する、医薬品を保管するための容器および方法が提供される。医薬品の貯蔵時間は、医薬品中の安定剤の喪失を低減させることによって改善される。貯蔵容器は、医薬品中の安定剤の移行を低減または抑制するのに有効な量の安定剤を含むポリオレフィンから形成される。ポリオレフィン容器は、m−クレゾールおよび/またはフェノールをインスリンの安定剤として含有するインスリンの安定化のために、エルカ酸アミドなどの脂肪酸アミドを用いて形成される。容器中に混合された脂肪酸アミドは、ポリオレフィン中へのm−クレゾールおよび/またはフェノールの移行速度を抑制および/または低減させて、インスリンの貯蔵寿命を延ばす。容器は、充填済みシリンジ、貯蔵バイアルまたはインスリンポンプの流路などのシリンジとすることができる。 | ||||||
| 18 | 導電性高分子を用いた流体搬送装置 | JP2009548513 | 2009-08-25 | JPWO2010023876A1 | 2012-01-26 | 生嶋 君弥; 君弥 生嶋; 横山 和夫; 和夫 横山 |
| 流体吸入吐出するポンプの機能を有し流体が内部に満たされるポンプ室(107,108)と、ポンプ室壁面の一部を構成する筺体部(102)と、電解伸縮を行う導電性高分子膜で形成されポンプ室壁面の一部を構成するダイヤフラム(103,104)と、内部に含まれた電解液の一部がダイヤフラムに接する電解液室(109)と、ダイヤフラムに電圧を印加する電源(110c)と、電解液室の壁面の一部を移動若しくは変形させてダイヤフラムの圧力を所定範囲内に維持する圧力維持部(1100,1110,1111,1112,1114,1115)とを備える。 | ||||||
| 19 | GRAPHENE ENHANCED ELASTOMERIC STATOR | EP15752204 | 2015-02-18 | EP3107863A4 | 2017-10-04 | SICILIAN JOSHUA ALAN |
| An enhanced elastomeric stator assembly and method of making the same is disclosed. The elastomeric stator may be structurally, thermally, and/or chemically enhanced through the incorporation of graphene particles, cross-linkable polymers, coupling agents that extend cross-links, and by the reduction of filler material. The graphene particles can be incorporated in functionalized or non-functionalized form or in a combination thereof, the functionalized graphene increasing the number of cross-links in the overall structure, thereby enhancing the structural robustness of the elastomeric stator. The compound can be formulated to have a relatively low viscosity and other characteristics that allow the material to flow through a mold cavity. | ||||||
| 20 | FLUIDISCHER AKTOR MIT VERFORMBARER VERSCHLUSSANORDNUNG UND LANGER LAGERFÄHIGKEIT | EP11782422.7 | 2011-11-14 | EP2643591A1 | 2013-10-02 | OTTO, Thomas; NESTLER, Jörg; GESSNER, Thomas |
| The invention relates to a fluidic actuator comprising a base arrangement (1, 10) having at least one cavity (6) formed therein, an activatable substance (20) inside the cavity (6), and a deformable closure arrangement. The activatable substance, for example, an electrolyte, can be at least partially converted by suitable activation and at the same time cause a pressure change in the cavity (6). The deformable closure arrangement (30; 4) serves to close the cavity (6). The deformable closure arrangement comprises a paraffin-containing element (30; 40) and upon activation of the activatable substance (20) can be deformed owing to the pressure change of the activatable substance. A corresponding production method comprises the following steps: preparing the base arrangement (1, 10); forming a cavity (6) open on at least one side in the base arrangement (1, 10); and closing the cavity with the deformable closure arrangement (30; 4) that comprises a paraffin-containing element (30; 40). | ||||||
QQ群二维码
意见反馈
意见反馈